Tafas v. Dudas et al
Filing
116
Unopposed MOTION for Extension of Page Limit by SmithKline Beecham Corporation, SmithKline Beecham PLC, Glaxo Group Limited. (Attachments: # 1 Proposed Order)(Reilly, Craig) Modified text on 12/26/2007 (klau, ).
Tafas v. Dudas et al
Doc. 116 Att. 1
Case 1:07-cv-00846-JCC-TRJ
Document 116-2
Filed 12/20/2007
Page 1 of 1
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA Alexandria Division ____________________________________ : : : Plaintiff, : : v. : : JON W. DUDAS, et al., : : Defendants. : ____________________________________: TRIANTAFYLLOS TAFAS,
1:07cv846 (JCC/TRJ)
CONSOLIDATED WITH ____________________________________ : SMITHKLINE BEECHAM : CORPORATION, : d/b/a GLAXOSMITHKLINE, et al., : : Plaintiffs, : : v. : 1:07cv1008 (JCC/TRJ) : JON W. DUDAS, et al., : : Defendants. : ____________________________________: ORDER Upon consideration of Plaintiff GlaxoSmithKline's ("GSK's") unopposed motion for leave to file an opening brief of forty-five (45) pages, it is hereby ORDERED that said motion is GRANTED. Entered this ____ day of December 2007. Alexandria, Virginia __________________________________ Hon. Thomas Rawles Jones, Jr. United States Magistrate Judge
1
Dockets.Justia.com
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?